Syngene offers formulation development services to help clients determine optimal dosage levels for therapeutic formulations in oral solid, liquid, and injectable forms. Our integrated services extend to new chemical entities (NCE), late-phase product development, and over-the-counter products with a focus on quality, speed, and cost-efficiency.
Our strong scientific team has broad experience and expertise in collaborative practices with a global customer base for formulation development services and analytical support.
We cater to pharmaceutical companies worldwide, providing extensive pre-formulation studies, toxicology formulation, formulation development, and analytical method development and validation. Our services include conducting stability studies as per the guidelines of The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and regulatory dossier preparation. We also perform process optimization and scale-up activities, and manufacturing of clinical batches in a current good manufacturing practice (cGMP) environment.